November 18, 2024 BioAge Corporate Presentation November 7, 2024 ObesityWeek 2024 oral presentation - The Apelin Receptor Agonist Azelaprag Reduces Weight Gain & Improves Body Composition in Diet-Induced Obese Mice November 5, 2024 ObesityWeek 2024 poster presentation - The APJ Agonist Azelaprag Improves Weight Loss and Body Composition in DIO Mice on a CB1 Antagonist June 21, 2024 ADA 2024 oral presentation - The Apelin Receptor Agonist Azelaprag Increases Weight Loss in Diet-Induced Obese Mice on Incretin Agonists and Restores Body Composition and Muscle Function to that of Lean Controls
November 7, 2024 ObesityWeek 2024 oral presentation - The Apelin Receptor Agonist Azelaprag Reduces Weight Gain & Improves Body Composition in Diet-Induced Obese Mice
ObesityWeek 2024 oral presentation - The Apelin Receptor Agonist Azelaprag Reduces Weight Gain & Improves Body Composition in Diet-Induced Obese Mice
November 5, 2024 ObesityWeek 2024 poster presentation - The APJ Agonist Azelaprag Improves Weight Loss and Body Composition in DIO Mice on a CB1 Antagonist
ObesityWeek 2024 poster presentation - The APJ Agonist Azelaprag Improves Weight Loss and Body Composition in DIO Mice on a CB1 Antagonist
June 21, 2024 ADA 2024 oral presentation - The Apelin Receptor Agonist Azelaprag Increases Weight Loss in Diet-Induced Obese Mice on Incretin Agonists and Restores Body Composition and Muscle Function to that of Lean Controls
ADA 2024 oral presentation - The Apelin Receptor Agonist Azelaprag Increases Weight Loss in Diet-Induced Obese Mice on Incretin Agonists and Restores Body Composition and Muscle Function to that of Lean Controls
